Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington’s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.

Michael I Sandstrom; Julien Pierre Andre Rossignol; Gary Dunbar

Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington’s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.

Michael I Sandstrom, Julien Pierre Andre Rossignol, Gary Dunbar

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Default journal
State	Published - 2007

Cite this

@article{b5a1edc8ee064f0299c46c436c810cfe,

title = "Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington{\textquoteright}s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.",

author = "Sandstrom, {Michael I} and Rossignol, {Julien Pierre Andre} and Gary Dunbar",

year = "2007",

language = "English",

journal = "Default journal",

}

Neurotrophic Enhancers as therapy for behavorial deficits in rodent models of huntington’s disease: use of gangliosides, substitued pyrimidines, and mesenchymal stem cells.

Fingerprint

Cite this